Ketamine Therapy in Calgary

Ketamine therapy is available in Calgary through CPSA-accredited clinics, including ATMA CENA's corporate clinic at 734 42 Ave SE. Most Calgary patients pay out-of-pocket for ketamine-assisted therapy; Alberta Blue Cross has covered psychedelic-assisted therapy for eligible plans since March 2024, and WCB Alberta covers ketamine for compensable injuries with prior authorization. This guide covers what's available in Calgary, who qualifies, what it costs, and how to begin.

Key takeaways

• ATMA CENA operates a corporate ketamine clinic in Calgary at 734 42 Ave SE; phone (403) 278-9020.
• Calgary IV ketamine for psychiatric use must be administered in a CPSA-accredited facility under March 2026 CPSA guidance; SQ/IM/oral/sublingual/intranasal routes are permitted in community settings.
• Alberta Blue Cross covers psychedelic-assisted therapy including ketamine for eligible plans (effective March 2024) — a Calgary-specific differentiator.
• WCB Alberta covers ketamine for compensable TRD, CRPS, and chronic pain with prior authorization (Form C1520).
• AHCIP covers physician consultations but does not cover the ketamine drug or administration for psychiatric use.

Who is ketamine therapy for in Calgary?

Ketamine therapy is most established for treatment-resistant major depressive disorder — depression that has not responded to at least two adequate antidepressant trials. It is also used for PTSD, anxiety disorders, OCD, bipolar depression (with mood-stabilizer coverage), and chronic pain conditions including CRPS and refractory neuropathic pain.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) places IV racemic ketamine as a third-line treatment for adults with TRD (Swainson et al., 2021). For Spravato (intranasal esketamine), Health Canada has approved use specifically for treatment-resistant MDD as of May 2020.

Calgary patients typically come to ketamine therapy after multiple antidepressants have failed, after severe symptoms have not responded to other modalities, or after an existing physician or psychiatrist has suggested exploring alternatives. For a full breakdown of eligibility and the screening process, see How to Qualify for Ketamine Therapy in Canada.

How does ketamine therapy work?

Ketamine acts on the brain's glutamate system, not the serotonin system targeted by SSRIs. The primary mechanism is antagonism at NMDA receptors, which triggers a downstream surge of glutamate, activates AMPA receptors, and stimulates BDNF release and synaptogenesis — the formation of new neural connections within 24 to 72 hours of a dose.

Where conventional antidepressants take four to six weeks to act, ketamine can produce antidepressant effects within 2 to 72 hours of a single IV dose (Lullau et al., 2023). When ketamine is paired with structured psychotherapy before, during, and after dosing — the model used at ATMA CENA — the treatment is called ketamine-assisted psychotherapy (KAP) or ketamine-assisted therapy (KAT). A 2022 systematic review of 17 KAP studies found that "psychotherapy, provided before, during, and following ketamine sessions, can maximize and prolong benefits" (Drozdz et al., 2022).

For more on the science and modalities, see What Is Ketamine Therapy?.

ATMA CENA's Calgary clinic

ATMA CENA's KAT model uses a three-phase structure: preparation sessions before dosing (intention-setting, screening, building the therapeutic alliance), the dosing session itself with the clinical team and therapist present, and integration sessions after each dose to translate insights into sustained behavioural change.

For broader Calgary clinic services beyond ketamine — including rTMS and SAP-access programs — see our Calgary clinic page.

Alberta's regulatory framework for ketamine

Alberta has the most developed ketamine regulatory framework in Canada. Three layers govern Calgary clinics:

Federal — Health Canada. Ketamine is a Schedule I controlled substance under the Controlled Drugs and Substances Act, legally permitted for medical use when prescribed by a licensed physician or nurse practitioner. Health Canada has approved ketamine as an anaesthetic; psychiatric use is off-label — a legal and common practice in Canadian medicine. Spravato (intranasal esketamine) is the only ketamine-class drug Health Canada approves for a psychiatric indication (treatment-resistant MDD).

Provincial — CPSA March 2026 guidance. The College of Physicians and Surgeons of Alberta issued Ketamine Prescribing, Administration and Oversight Expectations in March 2026. IV ketamine for psychiatric indications must be prescribed by a psychiatrist or by a physician in consultation with a psychiatrist, and administered in a CPSA-accredited non-hospital facility. Subcutaneous, intramuscular, oral, sublingual, and intranasal routes may be administered in community settings. Psychedelic-assisted psychotherapy (PAPT) using ketamine must be delivered in a CPSA-accredited facility regardless of route.

Provincial — Mental Health Services Protection Regulation (Alta Reg 114/2021). Sets the framework for psychedelic drug treatment services in Alberta, including facility licensing requirements through Alberta's PDTS program.

The practical effect for Calgary patients: facility accreditation and physician oversight are unusually robust here compared with most Canadian provinces.

Insurance coverage and Workers' Compensation in Alberta

AHCIP

Alberta Health Care Insurance Plan covers physician consultations and assessments — the medical visits at intake and follow-up. AHCIP does not cover the ketamine drug or administration for psychiatric indications. The Edmonton-area public hospital ketamine program at Misericordia and Grey Nuns operates as an exception within AHCIP for eligible TRD patients with psychiatrist referral; no equivalent public Calgary program exists as of May 2026.

Alberta Blue Cross

Alberta Blue Cross became the first Canadian insurer to cover psychedelic-assisted therapy when it expanded coverage in March 2024. Coverage applies to specific eligible plans and includes ketamine. Many Calgary employers offer Alberta Blue Cross as part of employee benefits — verify with your plan administrator whether your specific plan is eligible. See Alberta Blue Cross Coverage for Psychedelic Therapy for full criteria.

WCB Alberta

The Workers' Compensation Board of Alberta covers IV ketamine and Spravato for compensable injuries that result in:

• Treatment-resistant major depressive disorder
• Complex Regional Pain Syndrome (CRPS)
• Refractory neuropathic pain spreading to larger areas
• Moderate-to-severe MDD (esketamine specifically)

Authorization requires Form C1520 submitted by a treating specialist (neurologist, psychiatrist, physiatrist, or chronic pain specialist). Initial trial: 6 IV infusions or 4 weeks of Spravato induction. Procedure detail at wcb.ab.ca. For provider WCB pathway support, see Workers' Compensation Coverage in Alberta.

Veterans Affairs Canada

VAC covers ketamine as a non-formulary product for service-related TRD or chronic pain on a case-by-case basis. The treating physician submits a non-formulary request to VAC. In FY2024–25, 433 veterans received an average of CAD $10,109 in coverage (CBC News, June 2025).

What does ketamine therapy cost in Calgary?

Most Calgary patients pay out-of-pocket. Typical Calgary ranges as of 2026:

ATMA CENA's published KAT pricing: KAT Psychedelic Pathway from CAD $1,585 + $795 per additional session; KAT Psycholytic Pathway from CAD $1,530 + $740 per additional session; customized programs CAD $2,325–$6,930. A non-refundable deposit of CAD $300 applies to all programs. For the full Canadian pricing breakdown, see Ketamine Therapy Cost in Canada.

What to expect during a session

Calgary patients arrive at the clinic having fasted (typical for IV protocols) or eaten lightly per program instructions. Vitals are checked. The clinical team administers the dose — IV over 40 minutes, IM as a single injection, or sublingually held under the tongue for ~10 minutes. The acute experience typically lasts 45 to 90 minutes. Patients commonly describe altered time perception, mild visual or auditory shifts, an emotional softening, and a sense of distance from habitual thought patterns. The therapist or nurse stays with the patient throughout.

After the dosing window, patients rest in a recovery setting for another 30 to 60 minutes (longer for Spravato — Health Canada requires a minimum 2-hour observation). Patients cannot drive for at least 24 hours and need an escort home.

Calgary practical note: Calgary is a car-dependent city. Patients planning ketamine sessions need to arrange a designated driver or rideshare for the post-session 24-hour window. The 39 Ave SE CTrain station (Red Line) is a ~7-minute walk from ATMA CENA's 734 42 Ave SE location for patients arriving by transit.

Calgary's ketamine landscape

ATMA CENA shares the Calgary market with other regulated providers. SABI Mind operates a CPSA-accredited IV ketamine and IM clinic and was the first CPSA-accredited out-of-hospital IV ketamine clinic in Alberta. Bloom Health Institute provides KAT with psychiatrist oversight. The Sitting Room (Edmonton) and NeuroMed have referral relationships with Calgary practitioners. Each operates under the same March 2026 CPSA framework.

What distinguishes ATMA CENA in Calgary:

• Two dosing modes — psychedelic (higher dose, altered-state experience) and psycholytic (lower dose with patient engaged in talk therapy). Most clinics offer one or the other.
• KAP architecture — preparation, dosing, and integration are bundled rather than billed separately. This addresses the durability question raised by Wilkinson et al. (2017): adding integration psychotherapy after the acute course extended antidepressant durability (Wilkinson et al., 2017).
• SAP access pathways — for patients exploring psilocybin-assisted or MDMA-assisted therapy beyond ketamine, ATMA CENA has the regulatory infrastructure.
• Coordinated care — for patients whose primary therapist is in private practice, ATMA CENA's coordinated care program allows the existing therapeutic relationship to continue while ATMA CENA provides medical oversight and dosing-session infrastructure.

How to start ketamine therapy in Calgary

The path from inquiry to first session typically takes 2 to 4 weeks:

1. Information call. A brief intake call to confirm initial eligibility and explain the process.
2. Intake questionnaire. Online health-history form covering psychiatric history, medications, physical health, prior treatments.
3. Clinical consultation. A 45–60 minute video or in-person consultation with a physician, psychiatrist, or NP. Diagnostic confirmation, treatment-failure documentation, contraindication screening.
4. Medical clearance. Cardiovascular workup; baseline blood pressure (both arms), heart rate, ECG.
5. Informed consent and treatment plan. Sessions, modality, integration approach.
6. First session scheduled.

For WCB-eligible patients, Form C1520 must be submitted before treatment begins; ATMA CENA's clinical team supports the documentation. For Alberta Blue Cross-eligible patients, ATMA CENA can submit a coverage pre-determination.

Frequently asked questions

How much does ketamine therapy cost in Calgary? IV ketamine sessions typically cost CAD $500–$800; KAP programs CAD $685–$1,400 per session. ATMA CENA's published KAT programs run CAD $1,530–$6,930 depending on pathway and number of sessions. AHCIP does not cover psychiatric ketamine.

Is ketamine therapy covered by insurance in Calgary? Alberta Blue Cross covers psychedelic-assisted therapy including ketamine for eligible plans (effective March 2024). WCB Alberta covers compensable injuries with prior authorization. Most other private insurers cover Spravato with prior authorization but not generic IV/IM ketamine.

Do I need a referral to start ketamine therapy in Calgary?

Where is ATMA CENA's Calgary clinic? 734 42 Ave SE, Calgary, AB T2G 5N9. Phone (403) 278-9020. Hours Monday–Friday 8:00 AM–4:30 PM. The 39 Ave SE CTrain station (Red Line) is a ~7-minute walk away.

Can I drive after a ketamine session in Calgary? No. Patients cannot drive for at least 24 hours after a session. Arrange a designated driver or rideshare in advance. CTrain is an option for getting to the clinic but not for getting home post-session.

Is the public Edmonton ketamine program available to Calgary residents? The Misericordia/Grey Nuns Hospital public ketamine program is Edmonton-based. Eligibility is psychiatrist referral within the Covenant Health system; some Calgary residents may access it through their psychiatrist but logistics typically favour Calgary-based options.

What if I already have a Calgary psychiatrist? Continue working with your existing psychiatrist. ATMA CENA's clinical team coordinates with your prescriber where appropriate. The coordinated care model specifically supports patients who want to keep their existing therapeutic relationship intact.

How does ATMA CENA's KAT differ from infusion-only clinics? ATMA CENA uses a three-phase structure: preparation, dosing, integration. Infusion-only clinics focus on the medical administration of ketamine without bundled psychotherapy. Both are legitimate; the KAP model is supported by 2017 RCT evidence showing extended antidepressant durability (Wilkinson et al., 2017).

What conditions besides depression do you treat in Calgary? TRD, MDD with suicidal ideation, bipolar depression (with mood-stabilizer coverage), PTSD, anxiety disorders, OCD, chronic pain (CRPS, neuropathic). Specific eligibility is determined at clinical assessment.

Sources

1. ATMA CENA — Calgary Clinic: https://psychedelic.healthcare/psychedelic-therapy-calgary/
2. ATMA CENA — Psychedelic-Assisted Therapy (pricing): https://psychedelic.healthcare/
3. CPSA Ketamine Prescribing Guidance (March 2026): https://cpsa.ca/wp-content/uploads/2026/03/CPSA_Ketamine-Guidance_March-2026.pdf
4. CPSA PAPT Facility Accreditation: https://cpsa.ca/facilities-clinics/accreditation/psychedelic-assisted-psychotherapy/
5. Alberta MHSP Regulation 114/2021: https://www.canlii.org/en/ab/laws/regu/alta-reg-114-2021/latest/alta-reg-114-2021.html
6. Health Canada DPD — Spravato: https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98903
7. WCB Alberta — Ketamine and Esketamine: https://www.wcb.ab.ca/about-wcb/procedures-manual/pharmaceutical-ketamine-and-esketamine.html
8. PsyCan — Alberta Blue Cross Coverage Announcement (April 2024): https://psychedelicscanada.org/media/2024/04/psycan-welcomes-expansion-of-insurance-coverage-for-psychedelic-assisted-therapy-in-alberta
9. PR Newswire — ATMA CENA Celebrates Alberta Blue Cross Coverage (March 2024): https://www.atmajourney.com/alberta-blue-cross-covers-pat/
10. Swainson J, et al. (2021). CANMAT racemic ketamine recommendations. Can J Psychiatry. https://pubmed.ncbi.nlm.nih.gov/33174760/
11. Wilkinson ST, et al. (2017). CBT after ketamine. Psychother Psychosom. https://pmc.ncbi.nlm.nih.gov/articles/PMC5516265/
12. Drozdz SJ, et al. (2022). KAP systematic review. J Pain Res. https://pubmed.ncbi.nlm.nih.gov/35734507/
13. Lullau APM, et al. (2023). Antidepressant mechanisms of ketamine. Front Neurosci. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1223145/full

Related articles

• Ketamine Therapy in Canada
• What Is Ketamine Therapy?
• Ketamine Therapy Cost in Canada
• How to Qualify for Ketamine Therapy in Canada
• Ketamine Therapy for Depression
• Ketamine Therapy in Edmonton
• ATMA CENA Calgary Clinic — full services
• Alberta Blue Cross Coverage for Psychedelic Therapy
• Workers' Compensation Coverage for Psychedelic Therapy in Alberta

Last updated: 2026-05-05